Ovidrx
2 known investors
Ovid develops targeted small molecule therapies aimed at reducing seizures with improved safety and tolerability for people affected by epilepsies and other neurological brain conditions. The company operates in the biotech and drug development space focused on neurological diseases.
BiotechHealthtech
Investors Β· 2
Frequently asked questions
- What does Ovidrx do?
- Ovid develops targeted small molecule therapies aimed at reducing seizures with improved safety and tolerability for people affected by epilepsies and other neurological brain conditions. The company operates in the biotech and drug development space focused on neurological diseases.
- Who are Ovidrx's investors?
- Ovidrx's investors include BioBrit, Sanofi Ventures.